Federal Register of Legislation - Australian Government

Primary content

This instrument specifies classes of therapeutic goods for the purpose of section 23A of the Therapeutic Goods Act 1989.
Administered by: Health
Registered 11 Apr 2018

Commonwealth Coat of Arms of Australia

 

Therapeutic Goods (Classes of Therapeutic Goods) Instrument 2018

I, Larry Kelly, Acting Deputy Secretary, Health Products Regulation Group, a delegate of the Secretary of the Department of Health for the purposes of section 23A of the Therapeutic Goods Act 1989, make the following instrument under that section.

Dated 29 March 2018

(Signed by)

 

LARRY KELLY

Delegate of the Secretary of the Department of Health

 

 

 


1  Name

                   This instrument is the Therapeutic Goods (Classes of Therapeutic Goods) Instrument 2018.

2  Commencement

                   This instrument commences on the day after it is registered.

3  Definitions

                   In this instrument:

Act means the Therapeutic Goods Act 1989.

complementary medicine has the meaning given by regulation 2 of the Regulations.

OTC medicine has the meaning given by regulation 2 of the Regulations.

Regulations means the Therapeutic Goods Regulations 1990.

4  Classes of therapeutic goods

             (1)  For the purposes of section 23B of the Act, the following are the classes of therapeutic goods:

                     (a)  prescription and other medicines specified in subsection (2);

                     (b)  complementary medicines;

                     (c)  OTC medicines specified in items 1 to 3 of Part 3 of Schedule 10 to the Regulations, other than medicines specified in paragraph (2)(b), (c), (d) or (e);

                     (d)  other registrable therapeutic goods.

             (2)  For the purposes of paragraph (1)(a), the following prescription and other  medicines are specified:

                     (a)  prescription and other medicines specified in items 1 to 13 of Part 1 of Schedule 10 to the Regulations;

                     (b)  medicines containing oral nitrates for the treatment of heart disease;

                     (c)  nasal corticosteroids;

                     (d)  metered-dose asthma inhalers;

                     (e)  transdermal nicotine patches.